Investors Hangout Stock Message Boards Logo
  • Home
  • Mailbox
  • Boards
  • Favorites
  • Whats Hot!
  • Login - Join Now!
CytoDyn Inc CYDY
(Total Views: 724)
Posted On: 09/02/2020 8:39:51 PM
Post# of 153940
Posted By: CTMedic
Re: SAF #53859
SAF,

Your line of reasoning, IMO opinion, argues that the approval processes are objective and fair.

In spite of Dr. Pourhassan’s generosity toward the FDA, I don’t believe that is the case.

Exhibit 1: remdesevir EUA

Exhibit 2 : convalescent plasma after NIH thumbs down

Exhibit 3: expansion of remdesevir EUA.

I am not of the mind that if at first we don’t succeed, Eff it, it wasn’t worth it.

It is worth it. I am aware that I am now beating the beleaguered and still dead horse.

Nonetheless, I believe, and IMO the thousands of articles addressing CCR5 and everything from Alzheimer’s to Zika support my assertion, that leronlimab will transform medicine.

My wife is one of the post-Lyme/makes no sense/go see a shrink patients that medicine has dismissed and dismissed because the doctors don’t know what they don’t know (no offense intended. I don’t know what I do t know either).

We (ok, Cytodyn and associated physicians, I am an eager groupie) are on the precipice of transforming medicine and lives.

So whether the U.K. acts September 9 in response to the Cytodyn submission, the fight will continue.













(10)
(0)









  • New Post - Investors HangoutNew Post

  • Public Reply - Investors HangoutPublic Reply

  • Private Reply - Investors HangoutPrivate Reply

  • Board - Investors HangoutBoard

  • More - Investors HangoutMore

  • Keep Post - Investors HangoutKeep Post
  • Report Post - Investors HangoutReport Post
  • Home - Investors HangoutHome
  • Mailbox - Investors HangoutMailbox
  • Boards - Investors HangoutBoards
  • Favorites - Investors HangoutFavorites
  • Whats Hot! - Investors HangoutWhats Hot!
  • Settings - Investors HangoutSettings
  • Login - Investors HangoutLogin
  • Live Site - Investors HangoutLive Site